Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides
Temperton, Nigel J. ORCID: https://orcid.org/0000-0002-7978-3815, Quenelle, Debra C., Lawson, Keirissa M., Zuckerman, Jane M., Kern, Earl R., Griffiths, Paul D. and Emery, Vincent C. (2003) Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides. Journal of Medical Virology, 70 (1). pp. 86-90. ISSN 1096-9071 (on-line) (doi:10.1002/jmv.10357)
Full text not available from this repository.Abstract
A human cytomegalovirus (HCMV) glycoprotein B (gpUL55) DNA vaccine has been evaluated in BALB/c mice. Intramuscular immunization of these mice with pRc/CMV2-gB resulted in the
generation of high levels of gpUL55-specific antibody (geometric mean titer [GMT] 1:8900) and neutralizing antibody (GMT 1:74) after 2 booster doses given 5 and 10 weeks after primary inoculation. Emulsifying the construct with the aluminum phosphate gel adjuvant Adju-Phos
before immunization enhanced gpUL55-specific antibody responses (GMT 1:17800, P¼0.04). Coimmunization with CpG oligodeoxynucleotides was shown to enhance levels of neutralizing antibodies generated by immunization of mice with a pRc/CMV2-gB/Adju-Phos emulsion (P¼0.04). The results provide a rationale for evaluating combinations of other HCMV proteins for incorporation into a multi-target DNA vaccine, and for the optimization of adjuvant usage, to elicit enhanced levels of neutralizing antibodies.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | cytomegalovirus, DNA vaccine, CpG ODN, adjuvant |
Subjects: | Q Science > QR Microbiology R Medicine > RC Internal medicine |
Faculty / School / Research Centre / Research Group: | Faculty of Engineering & Science > Medway School of Pharmacy |
Related URLs: | |
Last Modified: | 16 Jul 2012 13:15 |
URI: | http://gala.gre.ac.uk/id/eprint/8567 |
Actions (login required)
View Item |